The Potential Impact of the Varicella Vaccine and New Antivirals on Ocular Disease Related to Varicella-zoster Virus
- 1 February 1997
- journal article
- review article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 123 (2) , 243-251
- https://doi.org/10.1016/s0002-9394(14)71042-6
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccineVaccine, 1995
- Varicella vaccineVaccine, 1995
- Successful treatment of sorivudine‐related agranulocytosis with granulocyte‐colony stimulating factorAmerican Journal of Hematology, 1995
- Herpes zoster in a normal child after varicella vaccinationPediatrics International, 1995
- FamciclovirDrugs, 1995
- Antiviral therapy of varicella-zoster virus infection in immunocompromised children — A prospective randomized study of aciclovir versus brivudinInfection, 1991
- AcyclovirDrugs, 1989
- Observations on the natural history of herpes zoster ophthalmicusCurrent Eye Research, 1987
- Antiviral sensitivities of the acute retinal necrosis syndrome virusCurrent Eye Research, 1987
- In vitro and in vivo antiviral activity of 1-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compoundsAntiviral Research, 1984